Fig. 3From: Development of a prognostic composite cytokine signature based on the correlation with nivolumab clearance: translational PK/PD analysis in patients with renal cell carcinomaThe predicted clearance of patients treated with everolimus (comparator arm of CheckMate 025), via the prognostic cytokine signature, was associated with OS. OS overall survival, predicted high CL patients predicted to have high clearance from the cytokine signature, predicted low CL patients predicted to have low clearance from the cytokine signatureBack to article page